Solubility Enhancement of Domperidone by Solvent Change In situ Micronization Technique

Abstract

Background:Domperidone (DOM), a dopamine receptor antagonist, is used as antiemetic for the treatment of gastroparesis, vomiting, and nausea. The low water solubility of DOM leads to a low dissolution rate and variable bioavailability. The aim of this study was to enhance the solubility of DOM by the preparation of micron-sized particles.Materials and Methods:The in situ micronization process was carried out using solvent change method in the presence of Soluplus® or PEG6000 as stabilizing agents. DOM was dissolved in appropriate solvent (acetone and methanol 1:1 v/v), and the stabilizing agent was dissolved in water (as nonsolvent). The nonsolvent was poured rapidly into the drug solution under stirring by a homogenizer, and the resultant was freeze dried. The crystalline shape and particle size of DOM and interaction of DOM with stabilizers were investigated by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and differential scanning calorimetry (DSC), and then, dissolution test was carried out.Results:Optimum formulation was composed of DOM (0.5%) and PEG6000 (0.1%) with the lowest particle size (3 μm) and the highest DE60% (95.95%) as compared to pure DOM (particle size of 13.4 μm and DE60% 52.18%).Conclusion:SEM micrographs showed uniform and spherical shape of microcrystals. FTIR, XRD, and DSC studies indicated the micron size of the microcrystals and no interference between the drug and the stabilizer.

Dissolution rates of various brands of proton pump inhibitors in combination with domperidone: an in vitro study

“…Its low water solubility results in low bioavailability. 12 The advantages of combining domperidone with other PPIs on pharmacokinetics have been well investigated. Ndraha and colleagues evaluated the impact of domperidone on the therapeutic efficacy of omeprazole.…”

“…For controlled-release dosage forms with HPMC as a polymer, the drug is released at a constant pace to maintain a constant dose and eventually establish a stable equilibrium. 12 A drug's dissolution profile is an important characteristic in its pharmaceutical development as it determines the rate and degree of absorption of the drug, which impacts its efficacy and safety. 17 The dissolving rate is affected by both intrinsic (solid state qualities of pure substance, such as particle size, surface area, crystal habit, and distribution) and extrinsic (hydrodynamics and test conditions) components.…”

Investigation on the Potential Application of Na-Attapulgite as an Excipient in Domperidone Sustained-Release Tablets

“…Due to its low water solubility, domperidone has limited oral bioavailability. In addition, it has a short biological half-life of 7 h [ 25 ]. The shorter biological half-life is better for developing sustained- and controlled-release formulations.…”